11646

協賛企業

[Sleep disturbances in Alzheimer's disease and other dementias.]

著者 Vecchierini MF
Psychol Neuropsychiatr Vieil.2010 Mar ; 8(1):15-23.
この記事をPubMed上で見るPubMedで表示

Centre du sommeil et de la vigilance, Hôpital Hôtel-Dieu, Paris.

(13view , 0users)
Sleep in dementias has been mainly studied in Alzheimer disease (AD). Sleep disturbances are found in 25 to 35% of subjects with AD. Subjective and objective disturbances are described. Long nocturnal awakenings disrupt sleep; total sleep time and sleep efficiency are reduced. Slow wave sleep is decreased and sometimes disappears. REM sleep percentage is also reduced and at a later stage of the disease, REM latency is increased. Sleep fragmentation can be associated with excessive daytime napping and sleepiness, and with other behavioral symptoms such as the sundowning syndrome and nocturnal agitation. Sleep abnormalities closely parallel the level of severity of dementia. The rest/activity ratio and the sleep-wake rhythms are more and more disturbed; the phase delay of the temperature rhythm is associated with the severity of the sundowning syndrome. Sleep disturbances and behavioral symptoms are the main reasons to institutionalize the patient. Sleep disturbances are related to multiple factors. Pathophysiological changes resulting of the disease itself, such as damage to the cholinergic pathways and to the circadian pacemaker in the suprachiasmatic nucleus, contribute to sleep changes in AD. Associated medical and psychiatric illness and their different treatments as well as environmental factors also induced sleep disturbances. Sleep-disordered breathing is a highly prevalent condition in AD patients and restless leg syndrome may account for nocturnal agitation. In Parkinson and in Lewy body dementias, sleep disturbances are more severe than in DA and REM sleep behavior disorder can precede by several years these diseases. Sleep attacks and sleepiness are very frequent in Parkinson disease. Specific etiologies should drive specific treatment. Several non pharmacologic treatments are usually associated to treat sleep disturbances in AD: information, increased daytime physical, social activities to minimize daytime naps and exposure to bright light. Some studies found advantages to associate melatonin in the evening.
PMID: 20215095 [PubMed - in process]
保存論文に追加 保存論文に追加

論文ランキング

週間人気論文ランキング - 閲覧数 (2010/07/24/ 09時更新)

Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation.

先週: 1位 ranksame 245view,2users 保存 要約を見る 要約

Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

先週: 3位 rankup 182view,0users 保存 要約を見る 要約

Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.

先週: 8位 rankup 78view,11users 保存 要約を見る 要約

Personality disorders and biosocial trait theories: The argument for radical legal reform.

先週: 2位 rankdown 76view,2users 保存 要約を見る 要約

The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs.

先週: 9位 rankup 68view,11users 保存 要約を見る 要約

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

先週: 5位 rankdown 68view,0users 保存 要約を見る 要約

Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts.

先週: 7位 ranksame 64view,1users 保存 要約を見る 要約

A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study.

先週: 10位 rankup 34view,28users 保存 要約を見る 要約

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

先週: 6位 rankdown 34view,0users 保存 要約を見る 要約

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

先週: 4位 rankdown 30view,0users 保存 要約を見る 要約
※view数:週間 user数:合計